Addex Therapeutics Ltd (ADXN) — Capital Reinvestment Ratio
Latest as of December 2020:
0.07x
Addex Therapeutics Ltd (ADXN) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow ($704.85K) in capital expenditures ($48.09K). See Addex Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
$704.85K
USD
Capital Expenditures
$48.09K
USD
Data as of
Dec 2020
Most recent filing
Addex Therapeutics Ltd Capital Reinvestment Ratio (2018–2018)
This chart tracks Addex Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Addex Therapeutics Ltd (2018–2018)
Year-by-year Capital Reinvestment Ratio for Addex Therapeutics Ltd from 2018 to 2018. For live market cap and broader valuation context, see ADXN market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.01x | $1.75 Million | $9.05K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow